Kyong Yeun Jung

Kyong Yeun Jung

Auto-generated profile, based on publicly available information

Kyong Yeun Jung

Department of Internal Medicine, Nowon Eulji Medical Center, Eulji University, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2015 in Nutrients
Verified
Journal Article
Open access
PDF file
DLDong-Hwa Lee
Dong-Hwa Lee
KPKyeong Seon Park
Kyeong Seon Park
SASoyeon Ahn
Soyeon Ahn
EKEu Jeong Ku
Eu Jeong Ku
KJKyong Yeun Jung
Kyong Yeun Jung
SLSoo Lim
Soo Lim
We evaluated the concordance between visceral fat area (VFA) estimated by bioelectrical impedance analysis (BIA) or computed tomography (CT) in Korean subjects with a wide range in age and body mass index (BMI). In 1006 individuals (mean age 55.2 ± 11.8 (19–87) years, mean BMI 26.0 ± 3.5 (17–46) kg/m2, 48.9% men), VFA quantified by CT was compared with VFA using multifrequency BIA machines within 15 days. Concordance rates were compared by age or BMI using correlation analysis, Bland-Altman plots, and intraclass correlation coefficient (ICC). Using BIA data, we established a regression formula to reflect CT-VFA. The mean VFAs by CT and BIA were 131.9 ± 57.3 cm2 and 110.5 ± 33.9 cm2, respectively (r = 0.605, p < 0.001). The mean difference was 21.4 ± 45.6 cm2, tending to increase with BMI. In women with BMI <25 kg/m2 or age <50 years, the VFAs by BIA were similar to those by CT (ICC = 0.496 in BMI <25 kg/m2 and ICC = 0.638 in age <50 years). However, the difference was greater in men with BMI ≥25 kg/m2 or age ≥50 years. Applying our formula, the difference between estimations decreased to 0.2 ± 38.2cm2. VFA estimated by BIA correlated well with that by CT, but a more accurate formula is needed to match CT data, particularly in older men or subjects with a high BMI.

30 June 2025 in Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
ELEun Kyung Lee
Eun Kyung Lee
MKMin Joo Kim
Min Joo Kim
SKSeung Heon Kang
Seung Heon Kang
BKBon Seok Koo
Bon Seok Koo
KKKyungsik Kim
Kyungsik Kim
JKJee Soo Kim
Jee Soo Kim
The increasing detection of papillary thyroid microcarcinoma (PTMC) has raised concerns regarding overtreatment. For low-risk PTMC, either immediate surgery or active surveillance (AS) can be considered. To facilitate the implementation of AS, the Korean Thyroid Association convened a multidisciplinary panel and developed the first Korean guideline. AS is recommended for adults with pathologically confirmed Bethesda V–VI PTMC who have no clinical evidence of lymph node or distant metastasis, gross extrathyroidal extension, invasion of the trachea or recurrent laryngeal nerve, or aggressive histology. A baseline assessment requires high-resolution neck ultrasound performed by experienced operators to exclude extrathyroidal extension, tracheal or recurrent laryngeal nerve invasion, and lymph node metastasis; contrast-enhanced neck computed tomography is optional. Patient characteristics, including age, comorbidities, and the capacity for long-term follow-up, should be thoroughly assessed. Shared decision-making should carefully weigh the benefits and risks of surgery versus AS, considering expected oncologic outcomes, potential complications, quality of life, anxiety, medical costs, and patient preference. Follow-up involves neck ultrasound and thyroid function tests every 6 months for 2 years and annually thereafter. Disease progression, defined as significant tumor growth or newly detected nodal or distant metastasis, warrants surgery. Despite remaining uncertainties, this guideline provides a structured framework to ensure oncologic safety and supports patient-centered AS.

25 January 2016 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
DLDong-Hwa Lee
Dong-Hwa Lee
KJKyong Yeun Jung
Kyong Yeun Jung
AHA Ram Hong
A Ram Hong
JKJung Hee Kim
Jung Hee Kim
Kyoung Min KimKyoung Min Kim
Kyoung Min Kim
SKSang Wan Kim
Sang Wan Kim
The purpose of this study was to determine the relationships among hip geometry, bone mineral density, and the risk of hip fracture in premenopausal women. The participants in this case–control study were 16 premenopausal women with minimal-trauma hip fractures (fracture group) and 80 age-and BMI-adjusted controls. Subjects underwent dual-energy X-ray absorptiometry (DXA) to assess BMD at the proximal femur and to obtain DXA-derived hip geometry measurements. The fracture group had a lower mean femoral neck and total hip BMD than the control group (0.721 ± 0.123 vs. 0.899 ± 0.115, p <0.001 for the femoral neck BMD and 0.724 ± 0.120 vs. 0.923 ± 0.116, p <0.001 for the total hip BMD). In addition, participants in the fracture group had a longer hip axis length (HAL; p = 0.007), narrower neck shaft angle (NSA; p = 0.008), smaller cross sectional area (CSA; p < 0.001) and higher cross sectional moment of inertia (CSMI; p = 0.004) than those in control group. After adjusting for BMD, the fracture group still had a significantly longer mean HAL (p = 0.020) and narrower NSA (p = 0.006) than the control group. BMD is an important predictor of hip fracture in premenopausal women. Furthermore, HAL and NSA are BMD-independent predictors of hip fracture in premenopausal women. Hip geometry may be clinically useful for identification of premenopausal women for whom active fracture prevention should be considered.

28 February 2023 in Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
SMShinje Moon
Shinje Moon
YSYOUNG SHIN SONG
YOUNG SHIN SONG
KJKyong Yeun Jung
Kyong Yeun Jung
ELEun Kyung Lee
Eun Kyung Lee
YPYoung Joo Park
Young Joo Park
Background: Thyroid cancer screening has contributed to the skyrocketing prevalence of thyroid cancer. However, the true benefit of thyroid cancer screening is not fully understood. This study aimed to evaluate the impact of screening on the clinical outcomes of thyroid cancer by comparing incidental thyroid cancer (ITC) with non-incidental thyroid cancer (NITC) through a meta-analysis.Methods: PubMed and Embase were searched from inception to September 2022. We estimated and compared the prevalence of high-risk features (aggressive histology of thyroid cancer, extrathyroidal extension, metastasis to regional lymph nodes or distant organs, and advanced tumor-node-metastasis [TNM] stage), thyroid cancer-specific death, and recurrence in the ITC and NITC groups. We also calculated pooled risks and 95% confidence intervals (CIs) of the outcomes derived from these two groups.Results: From 1,078 studies screened, 14 were included. In comparison to NITC, the ITC group had a lower incidence of aggressive histology (odds ratio [OR], 0.46; 95% CI, 0.31 to 0.7), smaller tumors (mean difference, −7.9 mm; 95% CI, −10.2 to −5.6), lymph node metastasis (OR, 0.64; 95% CI, 0.48 to 0.86), and distant metastasis (OR, 0.42; 95% CI, 0.23 to 0.77). The risks of recurrence and thyroid cancer-specific mortality were also lower in the ITC group (OR, 0.42; 95% CI, 0.25 to 0.71 and OR, 0.46; 95% CI, 0.28 to 0.74) than in the NITC group.Conclusion: Our findings provide important evidence of a survival benefit from the early detection of thyroid cancer compared to symptomatic thyroid cancer.

30 June 2025 in Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
SMShinje Moon
Shinje Moon
YSYOUNG SHIN SONG
YOUNG SHIN SONG
KJKyong Yeun Jung
Kyong Yeun Jung
ELEun Kyung Lee
Eun Kyung Lee
JLJeongmin Lee
Jeongmin Lee
OCon Behalf of the Korean Thyroid Association Clinical Guideline Committee
on Behalf of the Korean Thyroid Association Clinical Guideline Committee
In 2024, the Korean Thyroid Association (KTA) introduced a revised Risk Stratification System (K-RSS) for differentiated thyroid cancer, building upon the modified RSS (M-RSS) proposed by the American Thyroid Association in 2015. The K-RSS emphasizes the cumulative impact of coexisting clinical and pathological features, acknowledging that multiple intermediate-risk factors collectively indicate a higher recurrence risk. Histologic classification follows the 2022 World Health Organization classification, consolidating encapsulated follicular-patterned thyroid carcinomas, including invasive encapsulated follicular variant papillary thyroid carcinoma, follicular thyroid carcinoma, and oncocytic carcinoma of the thyroid gland, and stratifying them by the extent of capsular and vascular invasion. High-grade thyroid carcinoma is newly included. Updated criteria for tumor size and extrathyroidal extension (ETE) represent another significant change. BRAFV600E-mutated papillary thyroid carcinomas measuring 1 to 2 cm are now considered lower risk than previously classified in the M-RSS, while encapsulated follicular-patterned tumors larger than 4 cm are considered higher risk. Both minimal ETE and gross ETE confined to the strap muscles have been downgraded to low and intermediate risk, respectively. These changes are accompanied by updates regarding molecular profiling and surgical margin status. Collectively, these updates aim to minimize overtreatment in low-risk patients, while ensuring intensified management for those at higher risk.

30 May 2024 in International Journal of Thyroidology
Verified
Journal Article
Open access
PDF file
YPYoung Joo Park
Young Joo Park
ELEun Kyung Lee
Eun Kyung Lee
YSYOUNG SHIN SONG
YOUNG SHIN SONG
BKBon Seok Koo
Bon Seok Koo
HKHyungju Kwon
Hyungju Kwon
CACancer
Cancer
Young Joo Park, Eun Kyung Lee, Young Shin Song, Bon Seok Koo, Hyungju Kwon, Keunyoung Kim, Mijin Kim, Bo Hyun Kim, Won Gu Kim, Won Bae Kim, Won Woong Kim, Jung-Han Kim, Hee Kyung Kim, Hee Young Na, Shin Je Moon, Jung-Eun Moon, Sohyun Park, Jun-Ook Park, Ji-In Bang, Kyorim Back, Youngduk Seo, Dong Yeob Shin, Su-Jin Shin, Hwa Young Ahn, So Won Oh, Seung Hoon Woo, Ho-Ryun Won, Chang Hwan Ryu, Jee Hee Yoon, Ka Hee Yi, Min Kyoung Lee, Sang-Woo Lee, Seung Eun Lee, Sihoon Lee, Young Ah Lee, Joon-Hyop Lee, Ji Ye Lee, Jieun Lee, Cho Rok Lee, Dong-Jun Lim, Jae-Yol Lim, Yun Kyung Jeon, Kyong Yeun Jung, Ari Chong, Yun Jae Chung, Chan Kwon Jung, Kwanhoon Jo, Yoon Young Cho, A Ram Hong, Chae Moon Hong, Ho-Cheol Kang, Sun Wook Kim, Woong Youn Chung, Do Joon Park, Dong Gyu Na, Korean Thyroid Association Guideline Committee on the Managements of Thyroid Nodule and Cancer. Int J Thyroidol 2024;17:1-20. https://doi.org/10.11106/ijt.2024.17.1.1